Algeta ASA Company Profile, Contacts & Intelligence

Pharmaceutical ManufacturingOslo, No16 employeesFounded 1997
3 contacts with email or phone data3 with email data
Employees
16
Company source estimate
Reachable Contacts
3
Visible contacts with email or phone data
Contacts With Email
3
3 of 4 visible contacts
Departments
3
Mapped contact coverage

Algeta ASA Overview

March 6th The Bayer Group completed the voluntary takeover offer for Norwegian pharmaceutical company Algeta ASA, Oslo. As a result, Bayer now holds 98.2 % of the shares and voting rights in Algeta. Bayer intends to initiate a compulsory acquisition process in order to acquire the remaining shares of minority shareholders in Algeta in the coming days. Bayer intends to file for delisting of the Algeta shares from the Oslo Stock Exchange (OSE). Algeta is a company focused on developing, manufacturing and marketing novel targeted therapies for patients with cancer. Algeta's lead product Xofigo® injection (radium Ra 223 dichloride, radium-223; previously called Alpharadin) is an alpha particle-emitting pharmaceutical with an anti-tumor effect on bone metastases. In September 2009, Algeta signed an agreement with Bayer for the development and commercialization of Xofigo. Under the terms of this agreement, Bayer will develop, apply for health authority approvals worldwide and commercialize Xofigo globally. Algeta is eligible for royalties and milestones based on Bayer’s sales of Xofigo outside the US, and Algeta US is co-promoting Xofigo with Bayer in the US. Algeta is also evaluating the potential of Targeted Thorium Conjugates (TTCs), which are based on conjugating the alpha-emitter thorium-227 to targeting molecules, as a basis of a potential future pipeline of tumor-targeting alpha-pharmaceutical candidates. In December 2013, the Board of Directors of Algeta ASA announced that it had unanimously recommended the voluntary cash offer (the “Offer”) of NOK 362 per share from Bayer to acquire the entire issued share capital of Algeta.

Headquarters
Oslo, No
Website
algeta.com
Industry
Pharmaceutical Manufacturing
Founded
1997
NAICS
Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads

Algeta ASA Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

3 contacts with contact data
3 with email data in the visible sample.
3 departments represented
Visible contacts with email or phone data are mapped to these departments.
7 company-domain emails
Visible contacts using Algeta ASA's company email domain.
General
4
Executive
3
IT
1

Algeta ASA People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Algeta ASA Workforce Composition

Seniority breakdown across 15 visible profiles.

Individual contributor
8
Executive
3
Director
2
Manager
2

Algeta ASA Technology & Talent

Technology-related job titles represented in the visible people data.

Engineering
1

Compare Similar Companies to Algeta ASA

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Bayer Chemical Manufacturing 92.87K View company
Blueprint Medicines Biotechnology Research 795 View company
Clarity Pharmaceuticals Biotechnology Research 65 View company
Vistin Pharma AS Pharmaceutical Manufacturing 55 View company
Bayer Norge Pharmaceutical Manufacturing 48 View company
Oncoinvent ASA Biotechnology Research 43 View company
Circio Holding ASA Biotechnology Research 19 View company
Thor Medical ASA Biotechnology Research 19 View company
AlgiPharma AS Biotechnology Research 12 View company
Bionor Holding AS Biotechnology 5 View company